The role of eIF3 and its individual subunits in cancer
- PMID: 25450521
- DOI: 10.1016/j.bbagrm.2014.10.005
The role of eIF3 and its individual subunits in cancer
Abstract
Specific individual subunits of eIF3 are elevated or reduced in numerous human tumors, and their ectopic overexpression in immortal cells can result in malignant transformation. The structure and assembly of eIF3 and its role in promoting mRNA and methionyl-tRNAi binding to the ribosome during the initiation phase of protein synthesis are described. Methods employed to detect altered levels of eIF3 subunits in cancers are critically evaluated in order to conclude rigorously that such subunits may cause malignant transformation. Strong evidence is presented that the individual overexpression of eIF3 subunits 3a, 3b, 3c, 3h, 3i and 3m may cause malignant transformation, whereas underexpression of subunits 3e and 3f may cause a similar outcome. Possible mechanisms to explain the malignant phenotypes are examined. The involvement of eIF3 in cancer reinforces the view that translational control plays an important role in the regulation of cell proliferation, and provides new targets for the development of therapeutic agents. This article is part of a Special Issue entitled: Translation and Cancer.
Keywords: Initiation factors; Protein synthesis; Translational control; cancer; eIF3.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells.J Biol Chem. 2007 Feb 23;282(8):5790-800. doi: 10.1074/jbc.M606284200. Epub 2006 Dec 14. J Biol Chem. 2007. PMID: 17170115
-
Eukaryotic translation initiation factor 3 plays distinct roles at the mRNA entry and exit channels of the ribosomal preinitiation complex.Elife. 2016 Oct 26;5:e20934. doi: 10.7554/eLife.20934. Elife. 2016. PMID: 27782884 Free PMC article.
-
eIF3 targets cell-proliferation messenger RNAs for translational activation or repression.Nature. 2015 Jun 4;522(7554):111-4. doi: 10.1038/nature14267. Epub 2015 Apr 6. Nature. 2015. PMID: 25849773 Free PMC article.
-
The function and clinical significance of eIF3 in cancer.Gene. 2018 Oct 5;673:130-133. doi: 10.1016/j.gene.2018.06.034. Epub 2018 Jun 22. Gene. 2018. PMID: 29908282 Review.
-
Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.Crit Rev Oncol Hematol. 2006 Sep;59(3):169-80. doi: 10.1016/j.critrevonc.2006.03.005. Epub 2006 Jul 7. Crit Rev Oncol Hematol. 2006. PMID: 16829125 Review.
Cited by
-
Assembly of eIF3 Mediated by Mutually Dependent Subunit Insertion.Structure. 2016 Jun 7;24(6):886-96. doi: 10.1016/j.str.2016.02.024. Epub 2016 May 19. Structure. 2016. PMID: 27210288 Free PMC article.
-
Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.Cells. 2019 Nov 29;8(12):1542. doi: 10.3390/cells8121542. Cells. 2019. PMID: 31795417 Free PMC article. Review.
-
Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.J Cancer. 2018 Feb 28;9(6):1088-1095. doi: 10.7150/jca.23639. eCollection 2018. J Cancer. 2018. PMID: 29581788 Free PMC article.
-
eIF3 controls cell size independently of S6K1-activity.Oncotarget. 2015 Sep 15;6(27):24361-75. doi: 10.18632/oncotarget.4458. Oncotarget. 2015. PMID: 26172298 Free PMC article.
-
Protein synthesis control in cancer: selectivity and therapeutic targeting.EMBO J. 2022 Apr 19;41(8):e109823. doi: 10.15252/embj.2021109823. Epub 2022 Mar 22. EMBO J. 2022. PMID: 35315941 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
